---
figid: PMC7669777__10792_2020_1531_Fig5_HTML
figtitle: Hypothetical pathogenetic pathway of sarcoidosis
organisms:
- Homo sapiens
- Pieris brassicae
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC7669777
filename: 10792_2020_1531_Fig5_HTML.jpg
figlink: pmc/articles/PMC7669777/figure/Fig5/
number: F5
caption: 'Hypothetical pathogenetic pathway of sarcoidosis. Antigens interact with
  genetic, epigenetic and environmental factors to cause the following: a TLR2-mediated
  macrophage activation with the production of pro-inflammatory cytokines, such as
  TNF-α, IL-12, IL-18 and IL-6; b antigen presentation by MHC class II molecules on
  macrophages to CD4+ T cells; activation and differentiation of CD4+ T cells into
  Th1 and Th17.1 effector cells that produce IFN-γ and IL-2, and Th17 cells that produce
  IL-17; c impaired regulatory T cell response; d up-regulation of the mTORC1 pathway;
  e up-regulation of SAA followed by SAA aggregation within the granuloma and amplification
  of the Th1 immune response. Abbreviations. TLR: toll-like receptor; MHC: major histocompatibility
  complex; IL: interleukin; TNF: tumor necrosis factor; IFN: interferon; mTORC1: mechanistic
  target of rapamycin complex 1; SAA: serum amyloid A'
papertitle: 'Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic
  advancements.'
reftext: Rosanna Dammacco, et al. Int Ophthalmol. 2020;40(12):3453-3467.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7055358
figid_alias: PMC7669777__F5
figtype: Figure
redirect_from: /figures/PMC7669777__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7669777__10792_2020_1531_Fig5_HTML.html
  '@type': Dataset
  description: 'Hypothetical pathogenetic pathway of sarcoidosis. Antigens interact
    with genetic, epigenetic and environmental factors to cause the following: a TLR2-mediated
    macrophage activation with the production of pro-inflammatory cytokines, such
    as TNF-α, IL-12, IL-18 and IL-6; b antigen presentation by MHC class II molecules
    on macrophages to CD4+ T cells; activation and differentiation of CD4+ T cells
    into Th1 and Th17.1 effector cells that produce IFN-γ and IL-2, and Th17 cells
    that produce IL-17; c impaired regulatory T cell response; d up-regulation of
    the mTORC1 pathway; e up-regulation of SAA followed by SAA aggregation within
    the granuloma and amplification of the Th1 immune response. Abbreviations. TLR:
    toll-like receptor; MHC: major histocompatibility complex; IL: interleukin; TNF:
    tumor necrosis factor; IFN: interferon; mTORC1: mechanistic target of rapamycin
    complex 1; SAA: serum amyloid A'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CKAP5
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - CD83
  - IL6
  - IL12A
  - IL12B
  - TNF
  - IL18
  - MTOR
  - RPTOR
  - IL17A
  - SAA1
  - SAA2
  - SAA4
  - NELFCD
  - IL2
  - cd83
  - il6
  - tnfb
  - saa
  - Sarcoidosis
---
